IOC MEDICAL COMMISSION TOUGHENS STANCE AGAINST THE MISUSE OF ASTHMA MEDICATION
Lausanne, 17 May 2001 - For the first time, the IOC Medical Commission will require Olympic athletes, seeking authorization to use asthma medication during the Olympic Games, to provide clinical and laboratory proof of their ailment, the Medical Commission announced today.
Starting in Salt Lake City, a group of experts will examine the information supplied by the athletes and will determine, on a case by case basis, the need to conduct verification tests. When the proof is found to be insufficient, the Medical Commission will have the right to turn down the athlete’s request.
Numerous anti-asthmatics contain beta-2 agonists, which are on the list of prohibited substances. It has been proven that the systematic abuse of these substances produces anabolic effects.
The IOC Medical Commission is reinforcing its position on this matter to protect athletes from the dangers of mistaken diagnoses. It has noted a significant increase in the use of asthma medication containing beta-2 agonists during recent editions of the Olympic Games, especially in endurance sports.